Azaand polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors

Details for Australian Patent Application No. 2002211527 (hide)

Owner Merck & Co., Inc.

Inventors Perlow, Debra S.; Gomez, Robert P; Tran, Lekhanh; Jolly, Samson M.; Bennett, Jennifer J.; Guare, James P.; Embrey, Mark; Young, Steven D.; Fisher, Thorsten E; Langford, H. Marie; Funk, Timothy W.; Zhuang, Linghang; Egbertson, Melissa; Anthony, Neville J; Wai, John S.; Melamed, Jeffrey Y.; Kuo, Michelle S.

Agent Spruson & Ferguson

Pub. Number AU-B-2002211527

PCT Pub. Number WO02/30930

Priority 60/239,707 12.10.00 US; 60/281,656 05.04.01 US

Filing date 9 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 24 August 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

24 August 2006 Application Accepted

  Published as AU-B-2002211527

21 December 2006 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211528

2002211526